Hisamitsu Pharmaceutical Co Inc operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hisamitsu Pharmaceutical Co Inc with three other
companies in this sector in Japan:
Daito Pharmaceutical Company Limited
sales of 37.98 billion Japanese Yen [US$358.19 million]
of which 59%
was Drug Substance),
Moriroku Holdings Co Ltd
(170.01 billion Japanese Yen [US$1.60 billion]
of which 62%
was Resin processing products business), and
Kissei Pharmaceutical Company Limited
(71.71 billion Japanese Yen [US$676.19 million]
of which 86%
was Pharmaceutical Products).
Hisamitsu Pharmaceutical Co Inc reported sales of ¥145.93 billion (US$1.38 billion)
February of 2017.
decrease of 9.8%
versus 2016, when the company's sales were ¥161.85 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Hisamitsu Pharmaceutical Co Inc had sales
of ¥137.79 billion.